Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-03 LOWE CHRISTOPHER P. Interim CEO, COO & CFO Grant or award +175,000 265,000
2022-01-03 LOWE CHRISTOPHER P. COO & Chief Financial Officer Grant or award · Stock Option (right to buy) +125,000 125,000
2021-11-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +30,000 $2.23 $67K 90,000
2021-11-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (right to buy) −30,000 103,294
2021-10-05 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +4,963 $54.85 $272K 64,963
2021-10-05 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −4,963 $98.50 $489K 60,000
2021-10-05 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (Right to Buy) −4,963 95,037
2021-08-17 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +30,000 $2.23 $67K 60,000
2021-08-17 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (right to buy) −30,000 133,294
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +22,000 $2.23 $49K 52,000
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −9,158 $94.23 $863K 42,842
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −7,335 $95.02 $697K 35,507
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −2,330 $96.32 $224K 33,177
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −1,100 $97.28 $107K 32,077
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −2,077 $98.90 $205K 30,000
2021-08-16 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (right to buy) −22,000 163,294
2021-06-30 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +30,000 $2.23 $67K 30,000
2021-06-30 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (right to buy) −30,000 185,294
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise +20,000 $2.23 $45K 20,000
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Sale −7,724 $53.39 $412K 12,276

Page 1 of 2 · 29 trades